SOMAÍ Pharmaceuticals Partners with Cosma S.A. to Expand Cannabis-Based Products in Poland

SOMAÍ Pharmaceuticals, a Portugal-based marijuana company, has partnered with Cosma S.A., a Polish company focused on cannabis-based pharmaceutical advancements, to introduce a range of advanced cannabis-based products to Polish patients. The partnership aims to improve access to high-quality, innovative cannabis-based therapies for Polish patients, with Cosma S.A. acting as the marketing authorization holder (MAH) for both companies’ products.

Puerto Rico Gubernatorial Candidates’ Stances on Cannabis: From Medical to Decriminalization

As Puerto Rico prepares for gubernatorial elections, the candidates’ views on cannabis have come into focus. While recreational use remains illegal, the leading contenders – Jenniffer González, Jesús Manuel Ortiz, and Juan Dalmau – have all expressed support for varying levels of cannabis reform, ranging from expanding the medical cannabis industry to decriminalization.

Wake-and-Bake Trend Sparks Concern Among Experts

The growing trend of ‘wake-and-bake’ – consuming cannabis immediately upon waking – is raising concerns among experts, particularly its link to increased cannabis use throughout the day and its use as a coping mechanism for anxiety. This article explores the reasons behind this trend and highlights the need for further research on its potential consequences.

Nextleaf Solutions Reports Strong Q3 Revenue Growth, Focuses on Expansion

Nextleaf Solutions Ltd., a cannabis processor, announced its financial results for the third quarter ending June 30th, 2024, highlighting a 50% increase in gross revenue year-over-year to CA$4 million. The company also achieved a 37% year-over-year growth in net revenue, reaching CA$3,050,508. Despite a slight dip in gross profit compared to the previous year, Nextleaf remains focused on long-term growth through strategic investments in marketing, inventory, innovation, and product development.

Scroll to Top